COVID-19 clinical studies in Mexico 2025, by phase

Statista2026-04-11 收录

COVID-19临床试验

临床试验阶段分布

数据链接：

https://www.statista.com/statistics/1203597/mexico-covid-19-clinical-trials-phase/数据链接链接失效反馈

官方服务：

资源简介：

Number of registered clinical studies on COVID-19 in Mexico as of February 2025, by phase

Data for: Open COVID Trials (OCT) Project

开放科学评估

COVID-19临床试验

The COVID-19 pandemic has brought substantial attention to the systems used to communicate biomedical research. In particular, the need to rapidly and credibly communicate research findings has led ma

NIAID Data Ecosystem100

Additional file 4 of Standard of care for COVID-19 in randomized clinical trials registered in trial registries and published in preprint servers and scholarly journals: a cross-sectional study

COVID-19临床试验

标准治疗评估

Additional file 4 Supplementary file 4. Raw data from full-text journal manuscripts (Available at Open Science Framework: https://osf.io/he9c8/ )

Figshare2022-06-19 更新60

Additional file 2 of Standard of care for COVID-19 in randomized clinical trials registered in trial registries and published in preprint servers and scholarly journals: a cross-sectional study

COVID-19临床试验

治疗效果评估

Additional file 2 Supplementary file 2. Raw data from clinical trial registries (Available at Open Science Framework: https://osf.io/he9c8/ )

Figshare2022-06-17 更新10

Share of registered global clinical trials by phase 2025

临床试验阶段分布

药物研发统计

Share of registered clinical trials worldwide as of March 2025, by phase

Statista60

Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)

COVID-19临床试验

雷珠单抗治疗

ABSTRACT Introduction: Pro-inflammatory markers play a significant role in the disease severity of patients with COVID-19. Thus, anti-inflammatory therapies are attractive agents for potentially com

NIAID Data Ecosystem50

COVID-19 clinical studies in Mexico 2025, by phase

资源简介：

相关数据集